IMRA Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 37.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,430,048.78
IMARA Share Price & Price History
Current Price: $20.59
Price Change: ▲ Price Increase of +0.17 (0.83%)
As of 12/4/2025 01:00 AM ET
IMARA Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/19/2025 | Joseph P Lyssikatos | Insider | Sell | 12,500 | $22.33 | $279,125.00 | 902,688 |  |
| 11/7/2025 | Anish Patel | COO | Sell | 6,667 | $17.40 | $116,005.80 | 269,974 | |
| 10/20/2025 | Joseph P Lyssikatos | Insider | Sell | 12,500 | $22.08 | $276,000.00 | 915,188 | |
| 10/7/2025 | Anish Patel | COO | Sell | 6,667 | $20.10 | $134,006.70 | 276,641 | |
| 9/29/2025 | Benjamin Hohl | CFO | Sell | 3,250 | $20.40 | $66,300.00 | 23,000 | |
| 9/26/2025 | Joseph P Lyssikatos | Insider | Sell | 4,000 | $20.25 | $81,000.00 | 927,688 | |
| 9/23/2025 | Joseph P Lyssikatos | Insider | Sell | 1,500 | $20.03 | $30,045.00 | 931,688 | |
| 9/19/2025 | Joseph P Lyssikatos | Insider | Sell | 7,000 | $19.39 | $135,730.00 | 933,188 | |
| 9/8/2025 | Anish Patel | COO | Sell | 6,667 | $20.24 | $134,940.08 | 283,308 | |
| 8/27/2025 | Benjamin Hohl | CFO | Sell | 3,250 | $20.63 | $67,047.50 | 23,000 | |
| 8/21/2025 | Joseph P Lyssikatos | Insider | Sell | 7,500 | $20.01 | $150,075.00 | 940,188 | |
| 8/19/2025 | Joseph P Lyssikatos | Insider | Sell | 5,000 | $19.62 | $98,100.00 | 947,688 | |
| 8/7/2025 | Anish Patel | COO | Sell | 6,667 | $18.24 | $121,606.08 | 289,975 | |
| 7/28/2025 | Benjamin Hohl | CFO | Sell | 3,250 | $20.46 | $66,495.00 | 23,000 | |
| 7/21/2025 | Joseph P Lyssikatos | Insider | Sell | 12,500 | $22.29 | $278,625.00 | 952,688 | |
| 7/10/2025 | Benjamin Hohl | CFO | Sell | 1,000 | $22.66 | $22,660.00 | 23,000 | |
| 7/7/2025 | Anish Patel | COO | Sell | 6,667 | $19.79 | $131,939.93 | 296,642 | |
| 6/27/2025 | Benjamin Hohl | CFO | Sell | 3,250 | $20.91 | $67,957.50 | 23,000 | |
| 6/20/2025 | Joseph P Lyssikatos | Insider | Sell | 12,500 | $21.40 | $267,500.00 | 965,188 | |
| 6/9/2025 | Anish Patel | COO | Sell | 6,667 | $20.34 | $135,606.78 | 303,309 | |
| 6/3/2025 | Joseph P Lyssikatos | Insider | Sell | 7,500 | $20.03 | $150,225.00 | 977,688 | |
| 5/27/2025 | Benjamin Hohl | CFO | Sell | 3,250 | $16.18 | $52,585.00 | 23,000 | |
| 5/19/2025 | Joseph P Lyssikatos | Insider | Sell | 5,000 | $16.31 | $81,550.00 | 985,188 | |
| 5/7/2025 | Anish Patel | COO | Sell | 6,667 | $18.39 | $122,606.13 | 309,976 | |
| 5/1/2025 | Joseph P Lyssikatos | Insider | Sell | 5,030 | $20.07 | $100,952.10 | 992,658 | |
| 4/28/2025 | Benjamin Hohl | CFO | Sell | 3,250 | $18.69 | $60,742.50 | 23,000 | |
| 4/21/2025 | Joseph P Lyssikatos | Insider | Sell | 5,000 | $16.07 | $80,350.00 | 997,688 | |
| 4/7/2025 | Anish Patel | COO | Sell | 6,667 | $18.04 | $120,272.68 | 316,643 | |
| 2/22/2023 | Michael Gray | CFO | Sell | 2,464 | $18.68 | $46,027.52 | 6,902 | |
| 2/22/2023 | Rahul D Ballal | CEO | Sell | 8,215 | $18.64 | $153,127.60 | 21,958 | |
| 2/21/2023 | Commodore Capital Lp | Major Shareholder | Buy | 2,048 | $21.00 | $43,008.00 | 712,237 | |
| 1/30/2023 | Michael Gray | CFO | Sell | 899 | $15.68 | $14,096.32 | 9,366 | |
| 1/30/2023 | Rahul D Ballal | CEO | Sell | 2,828 | $15.64 | $44,229.92 | 30,174 | |
| 1/4/2023 | Braden Michael Leonard | Major Shareholder | Sell | 312,500 | $16.00 | $5,000,000.00 | 441,943 | |
| 12/30/2022 | Braden Michael Leonard | Major Shareholder | Sell | 5,000 | $16.16 | $80,800.00 | 57,500 | |
| 12/28/2022 | Braden Michael Leonard | Major Shareholder | Sell | 39 | $16.16 | $630.24 | 67,460 | |
| 12/22/2022 | Braden Michael Leonard | Major Shareholder | Sell | 269 | $16.24 | $4,368.56 | 79,730 | |
| 12/8/2022 | Ra Capital Management, L.P. | Major Shareholder | Buy | 2,650 | $15.00 | $39,750.00 | 807,856 | |
IMARA Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/15/2023 | Fairmount Funds Management LLC | 631,333 | $2.58M | 0.4% | N/A | 2.401% |  |
| 2/14/2023 | RA Capital Management L.P. | 3,250,724 | $13.30M | 0.3% | N/A | 12.365% | |
| 2/13/2023 | BML Capital Management LLC | 3,017,774 | $12.34M | 11.8% | N/A | 11.479% | |
| 2/8/2023 | JBF Capital Inc. | 200,200 | $0.82M | 0.2% | -4.7% | 0.762% | |
| 2/1/2023 | Great Valley Advisor Group Inc. | 13,660 | $56K | 0.0% | -35.0% | 0.052% | |
| 1/12/2023 | Marquette Asset Management LLC | 37,745 | $0.15M | 0.0% | -26.8% | 0.144% | |
| 11/16/2022 | Anson Funds Management LP | 28,356 | $65K | 0.0% | N/A | 0.108% | |
| 11/14/2022 | Tudor Investment Corp Et Al | 24,502 | $56K | 0.0% | -52.8% | 0.093% | |
| 11/10/2022 | MYDA Advisors LLC | 40,000 | $91K | 0.0% | N/A | 0.152% | |
| 11/9/2022 | JBF Capital Inc. | 210,000 | $0.48M | 0.1% | N/A | 0.799% | |
| 10/6/2022 | Marquette Asset Management LLC | 51,567 | $0.12M | 0.0% | -34.4% | 0.196% | |
| 8/16/2022 | Woodline Partners LP | 951,293 | $1.16M | 0.0% | -7.2% | 3.618% | |
| 7/15/2022 | Marquette Asset Management LLC | 78,579 | $96K | 0.0% | N/A | 0.299% | |
| 2/15/2022 | Laurion Capital Management LP | 264,681 | $0.60M | 0.0% | -11.8% | 1.007% | |
| 11/16/2021 | Two Sigma Advisers LP | 260,600 | $1.06M | 0.0% | N/A | 0.992% | |
| 11/16/2021 | Two Sigma Investments LP | 249,495 | $1.02M | 0.0% | N/A | 0.950% | |
| 11/16/2021 | Laurion Capital Management LP | 300,000 | $1.22M | 0.0% | N/A | 1.142% | |
| 11/15/2021 | Tudor Investment Corp Et Al | 51,923 | $0.21M | 0.0% | N/A | 0.198% | |
| 11/15/2021 | Rock Springs Capital Management LP | 829,102 | $3.38M | 0.1% | N/A | 3.155% | |
| 11/15/2021 | Lion Point Capital LP | 833,333 | $3.40M | 0.6% | N/A | 3.171% | |
| 11/12/2021 | Trexquant Investment LP | 19,646 | $80K | 0.0% | N/A | 0.075% | |
| 11/12/2021 | Renaissance Technologies LLC | 274,300 | $1.12M | 0.0% | +589.8% | 1.045% | |
| 11/9/2021 | BlackRock Inc. | 103,095 | $0.42M | 0.0% | +32.7% | 0.393% | |
| 8/16/2021 | Morgan Stanley | 429,033 | $3.39M | 0.0% | +33.1% | 1.635% | |
| 8/16/2021 | State Street Corp | 21,198 | $0.17M | 0.0% | -80.8% | 0.081% | |
Data available starting January 2016
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Read More on IMARA
Today's Range
Now: $20.59
52 Week Range
Now: $20.59
Volume
2,714 shs
Average Volume
138,364 shs
Market Capitalization
$540.16 million
P/E Ratio
411.88
Dividend Yield
N/A
Beta
1.09
Who are the company insiders with the largest holdings of IMARA?
